| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
"Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
|
Am J Surg Pathol
|
2011
|
2.72
|
|
2
|
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
|
J Clin Oncol
|
2009
|
2.07
|
|
3
|
Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors.
|
Clin Cancer Res
|
2010
|
1.89
|
|
4
|
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
|
J Clin Oncol
|
2012
|
1.84
|
|
5
|
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
|
N Engl J Med
|
2015
|
1.75
|
|
6
|
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
|
Cancer
|
2014
|
1.43
|
|
7
|
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
|
Cancer
|
2011
|
1.41
|
|
8
|
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).
|
J Med Chem
|
2012
|
1.27
|
|
9
|
Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors.
|
AJR Am J Roentgenol
|
2014
|
1.26
|
|
10
|
Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors.
|
Curr Opin Oncol
|
2012
|
1.23
|
|
11
|
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.
|
Cancer Res
|
2009
|
1.18
|
|
12
|
Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.
|
Cancer Res
|
2010
|
1.14
|
|
13
|
Leiomyosarcoma of the inferior vena cava: survival after aggressive management.
|
Ann Surg Oncol
|
2007
|
1.10
|
|
14
|
Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment.
|
AJR Am J Roentgenol
|
2011
|
1.03
|
|
15
|
Aberrant AKT activation drives well-differentiated liposarcoma.
|
Proc Natl Acad Sci U S A
|
2011
|
1.00
|
|
16
|
Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate.
|
Ann Surg Oncol
|
2009
|
1.00
|
|
17
|
Epithelioid soft tissue tumors.
|
Semin Oncol
|
2009
|
0.96
|
|
18
|
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
|
Cancer
|
2013
|
0.95
|
|
19
|
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
|
Cancer
|
2012
|
0.95
|
|
20
|
Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy.
|
Ann Surg Oncol
|
2011
|
0.91
|
|
21
|
Predictors of response to targeted therapies for gastrointestinal stromal tumors.
|
Arch Pathol Lab Med
|
2012
|
0.89
|
|
22
|
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
|
BMC Cancer
|
2014
|
0.88
|
|
23
|
Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.
|
Clin Cancer Res
|
2013
|
0.85
|
|
24
|
Modeling the in vivo case with in vitro nanotoxicity data.
|
Int J Toxicol
|
2008
|
0.82
|
|
25
|
Identification of succinate dehydrogenase-deficient bladder paragangliomas.
|
Am J Surg Pathol
|
2013
|
0.80
|
|
26
|
Is the nonlipomatous component of dedifferentiated liposarcoma always soft tissue on CT? Analysis of CT densities and correlation with rate of growth in 60 patients.
|
Abdom Imaging
|
2015
|
0.77
|
|
27
|
On the rotational intergrowth of hierarchical FAU/EMT zeolites.
|
Angew Chem Int Ed Engl
|
2014
|
0.76
|
|
28
|
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
|
J Pathol
|
2014
|
0.75
|
|
29
|
The challenge of choosing appropriate end points in single-arm phase II studies of rare diseases.
|
J Clin Oncol
|
2012
|
0.75
|
|
30
|
Specific targets in sarcoma and developmental therapeutics.
|
J Natl Compr Canc Netw
|
2010
|
0.75
|
|
31
|
Granuloma annulare heralding angioimmunoblastic T-cell lymphoma in a patient with a history of epstein-barr virus-associated B-cell lymphoma.
|
J Clin Oncol
|
2009
|
0.75
|